Skip to content
    BROWSE CERTIFIED COMPANIES
    Biogen Idec Ltd

    Biogen Idec Ltd

    Updated December 2022.

    About Biogen Idec Ltd

    Company Overview
    As pioneers in neuroscience, Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological diseases as well as related therapeutic adjacencies. Biogen has a leading portfolio of medicines to treat multiple sclerosis, introduced the first approved treatment for spinal muscular atrophy, and is providing the first and only US approved treatment to address a defining pathology of Alzheimer’s disease. Biogen also delivers biosimilar medicines to health systems. In 2020, Biogen launched a bold 20-year, $250 million initiative to address the deeply interrelated issues of climate, health, and equity.
    Company Size 280 UK-based Employees
    (Large)
    INDUSTRY BioPharma
    CONNECT
    Biogen Idec Ltd Head Office

    South East England, United Kingdom

    Employee Demographics

    Tenure
    • <2 years - 25%
    • 2-5 years - 38%
    • 6-10 years - 22%
    • 11-15 years - 12%
    • 16-20 years - 2%
    • Over 20 years - 1%

    Company Culture at Biogen Idec Ltd

    The employee experience below at Biogen Idec Ltd, compared to a typical company.

    93% of employees at Biogen Idec Ltd say it is a great place to work*, compared to 54% of employees at a typical UK based company.
    Biogen Idec Ltd
    93%
    Typical Company
    54%
    *Responses to the statement “Taking everything into account, I would say this is a great place to work.” vs. a typical UK company.

    99%

    This is a physically safe place to work.

    97%

    People here are treated fairly regardless of their race or ethnic origin.

    97%

    People here are treated fairly regardless of their sexual orientation.

    96%

    Our facilities contribute to a good working environment.

    95%

    I feel good about the ways we contribute to the community.

    Working at Biogen Idec Ltd

    Working at Biogen Idec Ltd
    Kylie Bromley, UKI GM and UK site lead
    Chris Viehbacher, President and Chief Executive Officer
    UK Site Building - 2022 in Maidenhead
    2022 Summer Site wide for all employees. Kylie Bromley, UKI GM and Wolfram Schmidt, President ECP
    Kylie Bromley, UKI GM & John Way, Head of International Regulatory. UKI Site leads kicking off 2022 Summer Site Wide.
    Care Deeply Day 2022 - team of Biogen employees supporting the local community
    Care Deeply Day 2022 team of Biogen employees supporting the local community

    Best Workplaces Lists

    Great Place To Work® is proud to recognise Biogen Idec Ltd on the following Best Workplaces Lists.

    Interested in a career at Biogen Idec Ltd, or just want to know more?

    To discover what sets Biogen Idec Ltd apart and explore relevant career opportunities, take a look at their website.

    Visit Their Website

    How to earn Great Place To Work Certification

    Watch this pre-recorded 5-minute webinar to learn the process for earning Great Place To Work Certification™

    Start Here
    Certification Webinar